ISSN: 0163-7258
Journal Home
Journal Guideline
Pharmacology and Therapeutics Q1 Unclaimed
Pharmacology and Therapeutics is a journal indexed in SJR in Pharmacology and Pharmacology (medical) with an H index of 211. It has an SJR impact factor of 3.085 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3.085.
Pharmacology and Therapeutics focuses its scope in these topics and keywords: therapeutic, cancer, drug, actions, biology, pharmacology, molecular, diseasethe, garlictargeting, diseases, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy:
Type of publications:
Publication frecuency: -
- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
3.085
SJR Impact factor211
H Index185
Total Docs (Last Year)460
Total Docs (3 years)40141
Total Refs6443
Total Cites (3 years)460
Citable Docs (3 years)12.95
Cites/Doc (2 years)216.98
Ref/DocOther journals with similar parameters
Pharmacological Reviews Q1
Annual Review of Pharmacology and Toxicology Q1
Perspectives in Medicinal Chemistry Q1
Drug Resistance Updates Q1
Trends in Pharmacological Sciences Q1
Compare this journals
Aims and Scope
Best articles by citations
Prostanoids and reactive oxygen species: Team players in endothelium-dependent contractions
View morePeroxisome proliferator-activated receptor gamma as a drug target in the pathogenesis of insulin resistance
View morePHARMACOLOGY & THERAPEUTICS
View moreTherapeutic relevance of pharmacogenetic factors in cardiovascular medicine
View moreThe regulation of nerve growth factor synthesis and delivery to peripheral neurons
View moreMarket structure and conduct in the pharmaceutical industry
View moreThe use of heterologously expressed drug metabolizing enzymes - state of the art and prospects for the future
View moreEthanol regulation of gamma-aminobutyric acidA receptors: genomic and nongenomic mechanisms
View morePotassium-competitive acid blockade: A new therapeutic strategy in acid-related diseases
View moreModification of alternative splicing pathways as a potential approach to chemotherapy
View moreDrug targeting via retrometabolic approaches
View moreClinical benefits and pharmacology of scutellarin: A comprehensive review
View moreCytochrome P450-catalyzed pathways in human brain: Metabolism meets pharmacology or old drugs with new mechanism of action?
View moreRole of the glutathione-glutathione peroxidase cycle in the cytotoxicity of the anticancer quinones
View moreStructure-activity relationships among guanine-quadruplex telomerase inhibitors
View moreAntimalarial activity of synthetic analogues of distamycin
View morePreface
View moreThe dynamics of drug resistance in Plasmodium falciparum
View moreMechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions
View moreSelective activation of E-type prostanoid3-receptors reduces myocardial infarct size
View moreAntitoxic immunity in cholera and enterotoxigenic escherichia coli (ETEC) diarrhea
View moreAdverse effects of established and new antiepileptic drugs: An attempted comparison
View moreMethyltransferase pharmacogenetics
View moreThe pneumonia virus of mice infection model for severe respiratory syncytial virus infection: identifying novel targets for therapeutic intervention
View more
Comments